A Wnt-Independent LGR4–EGFR Signaling Axis in Cancer Metastasis
Fei Yue,Weiyu Jiang,Amy T Ku,Adelaide I J Young,Weijie Zhang,Eric P Souto,Yankun Gao,Zihan Yu,Yi Wang,Chad J Creighton,Chandandeep Nagi,Tao Wang,Susan G Hilsenbeck,Xin-Hua Feng,Shixia Huang,Cristian Coarfa,Xiang H-F Zhang,Qingyun Liu,Xia Lin,Yi Li,Amy T. Ku,Adelaide I.J. Young,Eric P. Souto,Chad J. Creighton,Susan G. Hilsenbeck,Xiang H.-F. Zhang
DOI: https://doi.org/10.1158/0008-5472.can-21-1112
IF: 11.2
2021-06-07
Cancer Research
Abstract:Abstract Leucine-rich repeat-containing G protein–coupled receptors 4, 5, and 6 (LGR4/5/6) play critical roles in development and cancer. The widely accepted mechanism is that these proteins, together with their R-spondin ligands, stabilize Wnt receptors, thus potentiating Wnt signaling. Here we show that LGR4 enhanced breast cancer cell metastasis even when Wnt signaling was deactivated pharmacologically or genetically. Furthermore, LGR4 mutants that cannot potentiate Wnt signaling nevertheless promoted breast cancer cell migration and invasion in vitro and breast cancer metastasis in vivo. Multiomic screening identified EGFR as a crucial mediator of LGR4 activity in cancer progression. Mechanistically, LGR4 interacted with EGFR and blocked EGFR ubiquitination and degradation, resulting in persistent EGFR activation. Together, these data uncover a Wnt-independent LGR4–EGFR signaling axis with broad implications for cancer progression and targeted therapy. Significance: This work demonstrates a Wnt-independent mechanism by which LGR4 promotes cancer metastasis. See related commentary by Stevens and Williams, p. 4397
oncology